Neuromuscular Biology & Disease Groupat the Boston University School of Medicine
Our goals are to identify pathogenetic mechanisms and to develop new therapeutic strategies for neuromuscular diseases.
July 13th, 2012
Human Molecular Genetics has now published the paper from our Wellstone Group in which we examined DUX4-fl expression in FSHD and healthy individuals. (Abstract at PubMed)